Vendor, Rootstown, OH
Gateway Biotechnology, Inc.
UEI XDDXGL6JRRD9, CAGE 6HBC3
1 award and $650,000 obligated between May 23, 2025 and April 23, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $650,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942523C0071Definitive Contract, May 23, 2025, Full and Open Competition After Exclusion of Sources, 1 offers | Army Med Res Acq ActivityDefense Health Agency | DHA SBIR Phase Ii-- New Drug Product for Tinnitus.NAICS 541715, PSC AN12 | $650,000 |
- Places of performance
- Ohio
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 3 across 1 awards